Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenon as Adjuvant to Propofol in OPCAB Surgery
NCT01948765Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of xenon in coronary artery disease (CAD) (2 arms), sponsored by UZ Leuven. Primary endpoint: Intraoperative Haemodynamic Stability. Started Jun 2013; status: completed.
02
Drugs
xenon
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01948765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01948765.